McKesson Corporation (FRA:MCK)

Germany flag Germany · Delayed Price · Currency is EUR
616.60
+3.00 (0.49%)
At close: Jun 27, 2025, 10:00 PM CET
8.71%
Market Cap 77.50B
Revenue (ttm) 332.19B
Net Income (ttm) 3.05B
Shares Out n/a
EPS (ttm) 23.80
PE Ratio 25.42
Forward PE 19.55
Dividend 2.62 (0.43%)
Ex-Dividend Date Jun 2, 2025
Volume 2
Average Volume 1
Open 616.60
Previous Close 613.60
Day's Range 616.60 - 616.60
52-Week Range 427.70 - 646.00
Beta n/a
RSI 44.46
Earnings Date Aug 6, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1833
Employees 45,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MCK
Full Company Profile

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD Financial Statements

News

There is no news available yet.